Recent FTC Warning Letters Target CBD Medical Claims

September 10, 2019, the U.S. Federal Trade Commission (“FTC”) issued a news release announcing the recent distribution of warning letters to three companies advertising cannabidiol (“CBD”) products as a medical treatment option for a range of various illnesses. Cautioning that such unsubstantiated … Read more about Recent FTC Warning Letters Target CBD Medical Claims

Proposed California CBD Bill Suspended

Contrary to the bill’s projected outcome from earlier in the summer, California lawmakers will not make a decision on Assembly Bill-228 (“AB 228”) this year as the bill has stalled in the state legislature despite broad bipartisan interest and consumer support. Previously expected to be signed into … Read more about Proposed California CBD Bill Suspended

FDA Plans Release of CBD Regulations by Fall 2019

Cannabidiol (“CBD”) products have gained popularity across the country, but clear regulation from the Food and Drug Administration (“FDA”) is still forthcoming. This July, FDA announced an intent to fast- track the process to create these much-needed regulations. Currently, nearly 90% of CBD … Read more about FDA Plans Release of CBD Regulations by Fall 2019

Firm Attends FDA Hearing on Cannabis and Derived Products

  Last Friday, May 31, the U.S. Food and Drug Administration (“FDA”) held their first public hearing regarding cannabis and cannabis-derived products.  Influenced by the recent market boom of hemp and cannabidiol (“CBD”) products, the FDA’s hearing presented an opportunity for industry … Read more about Firm Attends FDA Hearing on Cannabis and Derived Products

Founder and Managing Partner Selected to Testify at FDA Public Hearing

It is with great pride that we announce that our Founder and Managing Partner, Dave Rodman has been selected by the U.S. Food and Drug Administration (“FDA”) to give oral testimony  regarding the safety of products containing cannabis-derived compounds, specifically cannabidiol (“CBD”), at the … Read more about Founder and Managing Partner Selected to Testify at FDA Public Hearing

USPTO Issues Hemp Guidance

Earlier this month, the United States Patent and Trademark Office (“USPTO”) released an official examination guide in response to the Agricultural Improvement Act of 2018 (“2018 Farm Bill”) and associated applications. While the guide offers some clarity for the federal registration of trademarks … Read more about USPTO Issues Hemp Guidance

TTB Rejects Use of CBD in Alcohol Beverages

The U.S. Alcohol and Tobacco Tax and Trade Bureau ("TTB") has joined the discussion regarding the legality of hemp and hemp-derived additives in consumable items. In a bureau-wide bulletin, the agency addressed wineries, distilleries, breweries, and importers hoping to add ingredients like … Read more about TTB Rejects Use of CBD in Alcohol Beverages

Firm Founder Offers Insight into CBD Legality

This week, in an article published by online magazine CBD Today, The Rodman Law Group's managing partner and founder, David Rodman, provided insight into the cannabidiol ("CBD") industry and it's current legal status. Citing the Agriculture Improvement Act of 2018, Mr. Rodman explained the risks … Read more about Firm Founder Offers Insight into CBD Legality